Disease Prevention Market By Stage (Primary Stage, Secondary Stage, and Tertiary Stage), By Prevention, By End-User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Report Overview

Disease Prevention Market size is expected to be worth around USD 792.7 Bn by 2032 from USD 221.0 Bn in 2022, growing at a CAGR of 14.0% during the forecast period from 2023 to 2032.

Disease prevention involves actions to reduce or eliminate exposure to risk that might increase the chances that an individual or group will incur disease, disability, or premature health. Preventing diseases through routine vaccination helps in improving health and economic stability. Increasing investments in immunization in low-middle countries could avert up to 36 million deaths and 24 million cases of poverty due to medical costs. The need for disease prevention is increasing in middle economies.

The national prevention activities include initiatives, regulatory programs, and policies such as National Tobacco Control Program and National Asthma Control Program that reduce exposure to harmful agents in the environment.

Driving factors

Health benefits of vaccination and increasing prevalence of chronic diseases driving the need for disease prevention

The rising prevalence of chronic diseases and the increasing geriatric population drive the need for preventive healthcare for the well-being of individuals. The vaccines provide immunity to fight against probable infections and help in improving the immune system. The diseases such as rabies, polio, tuberculosis, and smallpox have been prevented by vaccination. The demand for vaccination is more in children as their immune system is not fully developed. Vaccination helps in fighting against viruses and diseases by improving immune health.

Immunization is a key component of primary health care for well-being. The Flu vaccine is especially important for people with chronic health conditions, adults, and pregnant women. Most of the diseases, such as cancer, can be cured by detecting them in the early phase. The inventions in the healthcare field, such as gene sequencing, are capable of detecting the chances of disease occurrence in the early stage. Also, the use of Artificial Intelligence (AI) in the healthcare field helps healthcare professionals in the diagnosis of chronic diseases and surgery.

Restraining Factors

Lack of awareness and high services costs hampering the growth of the global disease prevention market

Disease prevention services are extremely helpful for the well-being of individuals, peoples are unaware of the concept, and its health benefits have a negative impact on market growth. The high cost of prevention, not having primary care providers, and lack of prevention services also have a negative impact on disease prevention market growth. Using fear arousal method prevention raises major ethical consideration issues. Not all preventive healthcare services are assessable to everybody, also restraining the development of the disease prevention market.

Stage Analysis

The primary stage segment has the largest market revenue share, with 36%

Based on the prevention stage, the disease prevention market is classified into primary stage, secondary stage, and tertiary stage. The primary stage prevention segment was dominant in the market, with the largest market revenue share of 36% in 2022. The growth of the segment is propelled by increasing governmental policies to minimize the harmful substances in the environment that cause diseases.

It prevents diseases or injury before it occurs. The primary benefit of primary prevention care intervention is the possibility of detecting early signs of diseases in a timely manner in order to allow diagnosis and management. The secondary stage prevention segment is expected to grow at the fastest CAGR during the forecast period owing to the increasing prevalence of chronic diseases and their diagnosis.

The secondary stage detects the diseases in its earliest stage, making treatment and diagnosis more effective. For example, mammograms to detect breast cancer, low-dose aspirin, and diet & exercise programs to prevent further heart attacks are coming under secondary prevention. Also, the use of external and internal condoms is an example of Multipurpose Prevention Technologies (MPTs) because they are effective in preventing STI and HIV transmission. Secondary prevention helps in preventing heart attack and stroke through drug therapy and counseling for high-risk individuals such as cardiovascular diseases (CVD).

Prevention Analysis

The vaccination segment is dominant in the disease prevention market.

By prevention method, the disease prevention market is classified into obesity prevention, sexually transmitted infections, chronic diseases prevention, cancer prevention, thrombosis prevention, vaccination, and other preventions. The vaccination prevention method was dominant in the market, with a significant market revenue share of 30% in 2022.

Vaccination is a primary prevention method that limits risk exposure and helps in improving the immunity of individuals to prevent the risk of diseases. Many infectious diseases can be prevented by using vaccination. Vaccination creates protective antibodies, such as protein, that help fight against infectious bacteria. The need for regular vaccination is increasing to keep children healthy, prevent outbreaks, and prevent the spreading of infectious diseases.

During the COVID-19 pandemic, the whole world was fighting against coronavirus. The governments started policies of vaccination to prevent the spreading of COVID-19. Baby’s immune system is not fully developed at birth, so they face a high risk of becoming infected and getting ill. The vaccines in babies improve the immune system of babies and build their natural defense. The chronic disease prevention segment is expected to grow at the fastest CAGR during the forecast period due to the increasing prevalence of chronic diseases with an increasing geriatric population. Prevention of chronic diseases can be done by avoiding the consumption of tobacco and alcohol.

End-User Analysis

The hospital segment is dominant, with a significant disease prevention market revenue share.

Based on end-user, the disease prevention market is classified into hospitals, clinics, diagnostic centers, and other end-users. The hospital segment was dominant in the disease prevention market, with the largest revenue share of 40% in 2022. Healthcare professionals in hospitals worldwide develop strategies and implementation of policies that protect immunocompromised in order to keep susceptible patients safe from healthcare-associated infections (HAIs).

Hospitals worldwide focus on public health surveillance to prevent the spreading of diseases. PPE, such as masks, goggles, and gowns, provide a physical barrier that prevents the hands, skin, nose, and mouth from coming in contact with infectious agents. Detecting viral antigen, immunoglobulin G (IgG), and IgM antibody prevention in diagnostic laboratories can be made using enzyme immunoassay testing. This is an essential element of disease surveillance for routine confirmation of infections and rapid identification of causes of outbreaks and epidemics.

Key Market Segments

By Stage

• Primary Stage
• Secondary Stage
• Tertiary Stage

By Prevention

• Obesity Prevention
• Sexually Transmitted Diseases
• Chronic Diseases Prevention
• Cancer Prevention
• Thrombosis Prevention
• Vaccination
• Other Preventions

By End-User

• Hospitals
• Clinics
• Diagnostic Centers
• Other End-Users

Growth Opportunity

Increasing research activities in the healthcare sector expected to create lucrative growth opportunities in the disease prevention market

The demand for disease prevention is increasing in middle-income countries, driving the need for disease prevention methods. Medical errors in hospitals cause a number of deaths. Preventive healthcare methods in hospitals help in avoiding errors in treatment. The research institutes and laboratories are focusing on next-generation sequencing techniques for rapid access to diseases and their treatment.

Governmental initiatives in several countries are implementing vaccination policies to prevent the spreading of diseases. This is expected to create lucrative growth opportunities in the global disease prevention market.

Latest Trends

Governmental bodies investing more and more in healthcare services

The governmental bodies in several countries announced that vaccination in babies of 1 to 2 months is mandatory to prevent diseases. Governments provide vaccines such as hepatitis B, diphtheria, tetanus, and whooping cough in hospitals free of cost. They are investing more and more in healthcare services. Thus, startups in disease prevention are working on research and development activities. Also, automation in hospital pharmacies and clinical decision support systems is increasing.

Regional Analysis

North America is dominant in the disease prevention market.

North America was dominant in the disease prevention market, with the largest revenue share of 39% in 2022. The growth of the region is attributed to increasing heart diseases, cancer, obesity, and Alzheimer’s diseases in the region. The regulatory bodies in North America implement health promotion and disease prevention programs that awaken people from sexually transmitted diseases.

Health promotion programs in North America are engaging and empowering individuals & communities to choose healthy behaviors and make changes that reduce the risk of developing chronic diseases. Asia Pacific is expected to grow at the fastest CAGR during the forecast period. The increasing chronic morbidity, loss of educational possibilities, and lack of awareness among individuals drive the need for disease prevention in the Asia Pacific.

Key Regions and Countries

North America

• US
• Canada
• Mexico

Western Europe

• Germany
• France
• The UK
• Spain
• Italy
• Portugal
• Ireland
• Austria
• Switzerland
• Benelux
• Nordic
• Rest of Western Europe

Eastern Europe

• Russia
• Poland
• The Czech Republic
• Greece
• Rest of Eastern Europe

APAC

• China
• Japan
• South Korea
• India
• Australia & New Zealand
• Indonesia
• Malaysia
• Philippines
• Singapore
• Thailand
• Vietnam
• Rest of APAC

Latin America

• Brazil
• Colombia
• Chile
• Argentina
• Costa Rica
• Rest of Latin America

Middle East & Africa

• Algeria
• Egypt
• Israel
• Kuwait
• Nigeria
• Saudi Arabia
• South Africa
• Turkey
• United Arab Emirates
• Rest of MEA

Key Players Analysis

The major key players in the disease prevention market are focusing on research and development activities. Key players are focusing on clinical research and drug discovery processes to detect and cure diseases. The top key players in the disease prevention market include Novartis AG, Edwards Lifesciences Corporation, Access Healthcare, Jazz Pharmaceuticals plc, Horizon Therapeutics Public Ltd Co., Penumbra, Inc., Carbon Health Inc., Accelerate Diagnostics, Inc., Medtronic, and Other Key Players.

Top Key Players in Disease Prevention Market

• Novartis AG
• Serum Institute of India Pvt. Ltd.
• Edwards Lifesciences Corporation
• Access Healthcare
• Jazz Pharmaceuticals plc
• Horizon Therapeutics Public Ltd Co.
• Penumbra, Inc.
• Carbon Health Inc.
• Accelerate Diagnostics, Inc.
• Medtronic Plc.
• Other Key Players

Recent Development

• In October 2022, Medtronic Plc. announced that it would work with GE Healthcare to support needs and care demands at Ambulatory Surgery Centers.
• In October 2020, Novartis AG developed therapeutic drugs to combat COVID-19.
• In 2020, The Serum Institute of India Pvt. Ltd. was the world’s largest vaccine producer by number of doses produced, manufacturing about 1.5 billion doses of vaccines per year.

Report Scope: